Skip to content
RUO · Research Use Only⚠ Cancer Concern✓ Free to read

TB-500

Also called Thymosin Beta-4 fragment

A 'healing' shot with a catch built into the label: what you buy is a short fragment, but the studies people cite are about a longer protein.

Updated 19 May 2026Read 3 minBacked by 60 studies
The quick version
What it is
A lab-made fragment loosely based on a healing protein (thymosin beta-4)
Is it FDA-approved?
No. Sold 'for research only'
How strong is the proof?
Very weak in people. Mostly animal data
How you take it
A shot under the skin
Typical result
Hard to say. No real human trials of this exact molecule
Biggest catch
Its mechanism overlaps with how tumors grow. A real cancer concern

Any word with a dotted underline is a science word — tap it for a plain-English meaning.

In plain words.

TB-500 is a short, lab-made . It is loosely based on the active part of a natural protein called thymosin beta-4, which helps tissue heal.

There is an important label trap here. The healing studies and the doping bans you read about are usually about the full protein (44 amino acids). What gets sold to people is TB-500, a shorter 17 fragment. They are not the same molecule, and the full-protein research does not transfer cleanly.

It is not . It is sold "for research only." People use it off-label for recovery.

What people use it for.

People use it to try to heal soft-tissue injuries faster, like muscle tears and tendon problems.

It is often stacked with BPC-157, another recovery .

It started out in the horse-racing world, where it was used and then banned.

Does it actually work?

Honestly, we do not know. There are essentially no randomized human trials of the TB-500 fragment.

There are around 120 animal studies and a handful of small early trials of the full-length protein (a different molecule). So the buzz is built on animal data and on a related molecule, not on real human proof of this product.

One telling sign: it is banned by WADA and by several horse-racing groups. That means regulators think the performance effect is real enough to police. That is not the same as a clean safety record.

what you’ve probably heard.

The claims floating around online, and how true they actually are.

BPC-157 plus TB-500 is the Wolverine stack that heals anything.

overblown

Both look interesting in animals, but neither has convincing human proof. Worse, stacking them doubles the blood-vessel-growth load, which is the exact mechanism that makes the cancer concern real. We avoid that pairing in anyone with a cancer history.

There are tons of studies backing TB-500.

half true

There are around 120 animal studies, but mostly of the full 44-piece protein, a different molecule. What gets sold is a shorter 17-piece fragment, and there are essentially no human trials of that. The research does not transfer cleanly.

It is just thymosin beta-4, a protein your body already makes.

not quite

What you inject is a short lab-made fragment loosely based on that protein, not the protein itself. The healing studies and doping bans people cite are usually about the full version, which is not the thing in the vial.

It is safe, athletes use it all the time.

no

It is banned by WADA and several horse-racing groups, which means regulators think the effect is real enough to police. There is no good human safety data, so the serious risks are simply unknown.

How you take it.

People take it as a shot under the skin, often 2-5 mg a week, for a short course.

It comes as a freeze-dried () powder you mix with ().

If you it with BPC-157, do not buy a pre-mixed "BPC+TB" vial. Buy two separate vials and mix each yourself. Pre-mixed blends are a common way to get underdosed, and you cannot adjust or stop one part on its own.

What to watch out for.

The serious stuff

The main worry is the mechanism. TB-500 promotes new blood-vessel growth () and cell movement. Tumors use the same tools to grow and spread.

  • Avoid it if you have a personal or family history of cancer.
  • Stacking it with BPC-157 doubles that blood-vessel-growth load. We avoid that in anyone with a cancer history.
  • It is banned by WADA. Do not use it in any tested sport.

We do not have good human safety data, so serious side effects are simply unknown. Talk to a real doctor. We are not your doctor.

Where people get it.

From safest to riskiest.

  • Brand. None. There is no TB-500.
  • . Contested. As of early 2026 most compounders stopped selling it. Where still sold, about $200-$400 a month, and those pharmacies are legally exposed.
  • Research-only (). The main supply. Sold "for research only," about $80-$200 a month. Some vendors ship the full protein at fragment prices, so a mass spec identity check matters.
  • . Overseas raw, about $15-$35 a month. Identity uncertain.

Whatever the source, it is banned for tested athletes.

Our honest take.

This is a cautious "maybe," and only in a narrow case. For a stubborn soft-tissue injury, in someone with no cancer history, a short, time-boxed course aimed at one clear question (did this tendon heal or not) is among the more defensible experiments.

It is not a chronic, everyday recovery tool. The blood-vessel-growth mechanism is real, and so is the cancer concern.

If you have any cancer history, skip it. If you do try it, run it on its own rather than stacked with BPC-157, and put it down once you have your answer.

The studies behind this.

We read the research so you don't have to. Here's where the facts on this page come from.

  1. 01Goldstein AL, et al. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert opinion on biological therapy. 2012;12(1):37-51. PMID: 22074294.
  2. 02Bubb MR. Thymosin beta 4 interactions. Vitamins and hormones. 2003;66:297-316. PMID: 12852258.
  3. 03Rahman OF, et al. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews. 2026;10(1). PMID: 41490200.
  4. 04Hannappel E. beta-Thymosins. Annals of the New York Academy of Sciences. 2007;1112:21-37. PMID: 17468232.
  5. 05Sun HQ, et al. The beta-thymosin enigma. Annals of the New York Academy of Sciences. 2007;1112:45-55. PMID: 17495248.
  6. 06Chen X, et al. Identification of glutamine as a potential therapeutic target in dry eye disease. Signal transduction and targeted therapy. 2025;10(1):27. PMID: 39837870.
  7. 07Zeng PM, et al. Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids. Stem cell reports. 2025;20(9):102601. PMID: 40816274.
  8. 08Faa G, et al. Thymosin β(4) and β(10) Expression in Human Organs during Development: A Review. Cells. 2024;13(13). PMID: 38994967.
  9. 09Pipes GT, et al. Cardioprotection by Thymosin Beta 4. Vitamins and hormones. 2016;102:209-26. PMID: 27450736.
  10. 10Belsky JB, et al. Thymosin beta 4 regulation of actin in sepsis. Expert opinion on biological therapy. 2018;18(sup1):193-197. PMID: 29508629.
  11. 11Bock-Marquette I, et al. Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies. International immunopharmacology. 2023;116:109741. PMID: 36709593.
  12. 12Low TL, et al. Thymosin beta 4. Methods in enzymology. 1985;116:248-55. PMID: 4088087.
  13. 13Maar K, et al. Thymosin Beta-4 Modulates Cardiac Remodeling by Regulating ROCK1 Expression in Adult Mammals. International journal of molecular sciences. 2025;26(9). PMID: 40362372.
  14. 14Sosne G. Thymosin beta 4 and the eye: the journey from bench to bedside. Expert opinion on biological therapy. 2018;18(sup1):99-104. PMID: 30063853.
  15. 15Kim J, et al. Potential role of thymosin Beta 4 in liver fibrosis. International journal of molecular sciences. 2015;16(5):10624-35. PMID: 26006229.
  16. 16Kim J, et al. Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells. Vitamins and hormones. 2016;102:121-49. PMID: 27450733.
  17. 17Sosne G, et al. Thymosin beta 4: A potential novel adjunct treatment for bacterial keratitis. International immunopharmacology. 2023;118:109953. PMID: 37018981.
  18. 18Othman O, et al. Thymosin beta 4 prevents systemic lipopolysaccharide-induced plaque load in middle-age APP/PS1 mice. International immunopharmacology. 2023;117:109951. PMID: 36878045.
  19. 19Song K, et al. Thymosin beta 4 attenuates PrP(106-126)-induced human brain endothelial cells dysfunction. European journal of pharmacology. 2020;869:172891. PMID: 31877278.
  20. 20Kim S, et al. Thymosin Beta 4 Protects Hippocampal Neuronal Cells against PrP (106-126) via Neurotrophic Factor Signaling. Molecules (Basel, Switzerland). 2023;28(9). PMID: 37175330.
  21. 21Bako P, et al. Thymosin beta-4 - A potential tool in healing middle ear lesions in adult mammals. International immunopharmacology. 2023;116. PMID: 38706788.
  22. 22Zhang Y, et al. Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion. Cardiovascular research. 2025;121(17):2747-2758. PMID: 41229390.
  23. 23Vasilopoulou E, et al. Loss of endogenous thymosin β(4) accelerates glomerular disease. Kidney international. 2016;90(5):1056-1070. PMID: 27575556.
  24. 24Tan WKY, et al. Sources of variability in quantifying circulating thymosin beta-4: literature review and recommendations. Expert opinion on biological therapy. 2018;18(sup1):141-147. PMID: 29502471.
  25. 25Wirsching HG, et al. Thymosin β 4 gene silencing decreases stemness and invasiveness in glioblastoma. Brain : a journal of neurology. 2014;137(Pt 2):433-48. PMID: 24355709.
  26. 26Jiang Y, et al. Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease. Chronic diseases and translational medicine. 2017;3(3):165-168. PMID: 29063072.
  27. 27Zhang X, et al. Enhancing fat graft survival: thymosin beta-4 facilitates mitochondrial transfer from ADSCs via tunneling nanotubes by upregulating the Rac/F-actin pathway. Free radical biology & medicine. 2025;228:281-298. PMID: 39761767.
  28. 28Gao X, et al. Thymosin Beta-4 Induces Mouse Hair Growth. PloS one. 2015;10(6):e0130040. PMID: 26083021.
  29. 29Nachmias VT, et al. Thymosin beta 4 (T beta 4) in activated platelets. European journal of cell biology. 1993;61(2):314-20. PMID: 8223720.
  30. 30Low TL, et al. Chemical characterization of thymosin beta 4. The Journal of biological chemistry. 1982;257(2):1000-6. PMID: 7054160.
  31. 31Sosne G, et al. Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy, Dry Eye, and Ocular Surface Diseases. Vitamins and hormones. 2016;102:277-306. PMID: 27450739.
  32. 32Larsson LI, et al. Localization of thymosin beta-4 in tumors. Annals of the New York Academy of Sciences. 2007;1112:317-25. PMID: 17495241.
  33. 33Smart N, et al. Thymosin beta-4 is essential for coronary vessel development and promotes neovascularization via adult epicardium. Annals of the New York Academy of Sciences. 2007;1112:171-88. PMID: 17495252.
  34. 34Zalvide JB, et al. Regulation of thymosin beta 4 mRNA levels during cell proliferation. Cell proliferation. 1995;28(2):85-91. PMID: 7534483.
  35. 35Lin C, et al. Thymosin beta-4 participate in antibacterial immunity and wound healing in black tiger shrimp, Penaeus monodon. Fish & shellfish immunology. 2023;141:109065. PMID: 37689229.
  36. 36Cierniewski CS, et al. Adhesive and proteolytic phenotype of migrating endothelial cells induced by thymosin beta-4. Annals of the New York Academy of Sciences. 2007;1112:123-39. PMID: 17495245.
  37. 37Badamchian M, et al. Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. International immunopharmacology. 2003;3(8):1225-33. PMID: 12860178.
  38. 38Yu FX, et al. Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins. The Journal of biological chemistry. 1993;268(1):502-9. PMID: 8416954.
  39. 39Davison G, et al. The potential use and abuse of thymosin β-4 in sport and exercise science. Journal of sports sciences. 2013;31(9):917-8. PMID: 23421910.
  40. 40Sosne G, et al. Thymosin beta-4 and the eye: I can see clearly now the pain is gone. Annals of the New York Academy of Sciences. 2007;1112:114-22. PMID: 17495249.
  41. 41Kuo CY, et al. Aberrant Expression of Thymosin Beta-4 Correlates With Advanced Disease and BRAF V600E Mutation in Thyroid Cancer. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 2022;70(10):707-716. PMID: 36321670.
  42. 42Di H, et al. Thymosin beta 4: An emerging therapeutic candidate for kidney diseases. Peptides. 2026;195:171467. PMID: 41570941.
  43. 43Varghese S, et al. Rat thymosin beta 4 gene. Intron-containing gene and multiple retroposons. The Journal of biological chemistry. 1991;266(22):14256-61. PMID: 1650352.
  44. 44Kleinman HK, et al. Thymosin β4 Promotes Dermal Healing. Vitamins and hormones. 2016;102:251-75. PMID: 27450738.
  45. 45Li W, et al. In Vitro Study of Thymosin Beta 4 Promoting Transplanted Fat Survival by Regulating Adipose-Derived Stem Cells. Aesthetic plastic surgery. 2024;48(11):2179-2189. PMID: 38409346.
  46. 46Otero A, et al. Transcript levels of thymosin beta 4, an actin-sequestering peptide, in cell proliferation. Biochimica et biophysica acta. 1993;1176(1-2):59-63. PMID: 8452879.
  47. 47Shimamura R, et al. Expression of the thymosin beta 4 gene during differentiation of hematopoietic cells. Blood. 1990;76(5):977-84. PMID: 2393720.
  48. 48Kim J, et al. Thymosin beta-4 regulates activation of hepatic stellate cells via hedgehog signaling. Scientific reports. 2017;7(1):3815. PMID: 28630423.
  49. 49Rahaman KA, et al. Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2024;1235:124033. PMID: 38382158.
  50. 50Ye C, et al. Therapeutic potential of thymosin beta 4 in a variety of diseases. Asian journal of surgery. 2024;47(11):4865. PMID: 38824027.
  51. 51Drum CL, et al. Thymosin Beta-4 Is Elevated in Women With Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association. 2017;6(6). PMID: 28611096.
  52. 52Choi J, et al. Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways. International journal of molecular sciences. 2023;24(4). PMID: 36834849.
  53. 53Malinda KM, et al. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 1997;11(6):474-81. PMID: 9194528.
  54. 54Hannappel E, et al. Biosynthesis rates and content of thymosin beta 4 in cell lines. Archives of biochemistry and biophysics. 1985;240(1):236-41. PMID: 2990345.
  55. 55Yu FX, et al. Effects of thymosin beta 4 and thymosin beta 10 on actin structures in living cells. Cell motility and the cytoskeleton. 1994;27(1):13-25. PMID: 8194107.
  56. 56Zhu Z, et al. Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4. European journal of pharmacology. 2021;908:174351. PMID: 34280397.
  57. 57De La Cruz EM, et al. Thymosin-beta(4) changes the conformation and dynamics of actin monomers. Biophysical journal. 2000;78(5):2516-27. PMID: 10777749.
  58. 58Han HJ, et al. Thymosin beta 4-Induced Autophagy Increases Cholinergic Signaling in PrP (106-126)-Treated HT22 Cells. Neurotoxicity research. 2019;36(1):58-65. PMID: 30552633.
  59. 59Sanders MC, et al. Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proceedings of the National Academy of Sciences of the United States of America. 1992;89(10):4678-82. PMID: 1584803.
  60. 60Wang YY, et al. Thymosin Beta-4 Recombinant Adeno-associated Virus Enhances Human Nucleus Pulposus Cell Proliferation and Reduces Cell Apoptosis and Senescence. Chinese medical journal. 2015;128(11):1529-35. PMID: 26021512.

We're not your doctor, and this isn't medical advice. It's a plain-English summary of what the research says, so you can have a smarter conversation with someone who is.

Keep up with this stuff

Want the rest of the peptide world, in plain English?

New breakdowns, safety updates, and what's actually worth your money. Free. Unsubscribe in one click.